Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Researchers shine light on ‘molecular butcher’ using neutron beams

Tucked away inside cell membranes, a molecular butcher does the bidding of healthy cells but also of disease agents. It has been operating out of clear view, but researchers just shined a mighty spotlight on it.

2 Feb 2018

Low levels of alcohol helps the brain clear away toxins, study shows

While a couple of glasses of wine can help clear the mind after a busy day, new research shows that it may actually help clean the mind as well.

2 Feb 2018

Scientists discover the genetic cause of immune disorders

Scientists from the Cincinnati Children’s have successfully identified a gene mutation that affects T cell function and promotes immune disorders.

1 Feb 2018

Inadequate oxygen levels during sleep increase risk of developing Alzheimer's disease

Inadequate oxygen levels during sleep can damage the brain and increase the risk of developing Alzheimer's disease, University of Queensland researchers have found.

31 Jan 2018

Interrupted sleep could be an early sign of Alzheimer’s disease, finds new study

Disrupted circadian rhythm patterns could be an early sign of Alzheimer's disease, finds new study.

30 Jan 2018

Circadian rhythm disruptions occur much earlier in people at risk of Alzheimer's

People with Alzheimer's disease are known to have disturbances in their internal body clocks that affect the sleep/wake cycle and may increase risk of developing the disorder.

29 Jan 2018

Enhanced lifestyle counselling could protect against Alzheimer’s disease, finds new study

Enhanced lifestyle counselling could prevent cognitive decline in people who are genetically predisposed to develop Alzheimer’s disease, finds new study.

29 Jan 2018

Study sheds light on key protein involved in memory formation and brain growth

Ask a nonscientist what memories are made of and you'll likely conjure images of childhood birthday parties or wedding days. Charles Hoeffer thinks about proteins.

27 Jan 2018

Aerobic exercise may improve cognitive symptoms in older adults at risk for AD

Alzheimer's disease (AD) is a brain disorder that destroys memory and thinking skills over time. It is the most common form of dementia in older adults.

27 Jan 2018

Virtual reality provides new insight into how different brain areas assemble memories

Virtual reality is helping neuroscientists at the University of California, Davis, get new insight into how different brain areas assemble memories in context.

27 Jan 2018

Scientists discover promising new target to fight a class of viruses

Scientists at the Morgridge Institute for Research have discovered a promising new target to fight a class of viruses responsible for health threats such as Zika, polio, dengue, SARS and hepatitis C.

25 Jan 2018

Enhanced lifestyle counseling prevents cognitive decline even in genetically susceptible people

Enhanced lifestyle counseling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer's disease, according to a new study published in JAMA Neurology.

25 Jan 2018

Discovery may advance stem cell therapies, gene-targeting treatments for neurological diseases

New research from Sanford Burnham Prebys Medical Discovery Institute is among the first to describe how an mRNA modification impacts the life of neural stem cells.

24 Jan 2018

Personality changes occur early on during development of Alzheimer's disease, research finds

A key feature of Alzheimer's disease is memory loss and losing one's ability to think and make decisions (also called "cognitive ability"). Those changes can begin slowly, during a phase called "mild cognitive impairment" (or MCI). A variety of diseases can cause MCI, but the most common is Alzheimer's disease.

23 Jan 2018

Curcumin could provide meaningful cognitive benefits, study suggests

Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin -- the substance that gives Indian curry its bright color -- improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.

23 Jan 2018

Neuronal loss is very limited in Alzheimer’s disease, shows new study

Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses.

17 Jan 2018

Postcard from Sacramento: Alzheimer’s ‘looks like me, it looks like you’

Until last year, Jackie Coleman was a disability rights lawyer — a good one, too.

16 Jan 2018

Study reveals how devastating mitochondrial diseases strike families without any previous history

Researchers have shown for the first time how children can inherit a severe - potentially fatal - mitochondrial disease from a healthy mother.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark of the immune-mediated neurological disorder multiple sclerosis.

12 Jan 2018

Alzheimer's Disease News and Research

Further Reading

Researchers shine light on ‘molecular butcher’ using neutron beams

Low levels of alcohol helps the brain clear away toxins, study shows

Scientists discover the genetic cause of immune disorders

Inadequate oxygen levels during sleep increase risk of developing Alzheimer's disease

Interrupted sleep could be an early sign of Alzheimer’s disease, finds new study

Circadian rhythm disruptions occur much earlier in people at risk of Alzheimer's

Enhanced lifestyle counselling could protect against Alzheimer’s disease, finds new study

Study sheds light on key protein involved in memory formation and brain growth

Aerobic exercise may improve cognitive symptoms in older adults at risk for AD

Virtual reality provides new insight into how different brain areas assemble memories

Scientists discover promising new target to fight a class of viruses

Enhanced lifestyle counseling prevents cognitive decline even in genetically susceptible people

Discovery may advance stem cell therapies, gene-targeting treatments for neurological diseases

Personality changes occur early on during development of Alzheimer's disease, research finds

Curcumin could provide meaningful cognitive benefits, study suggests

Neuronal loss is very limited in Alzheimer’s disease, shows new study

Postcard from Sacramento: Alzheimer’s ‘looks like me, it looks like you’

Study reveals how devastating mitochondrial diseases strike families without any previous history

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News